CHICAGO--(BUSINESS WIRE)--CytoCore (OTCBB:CYCR), the biopharmaceutical research and medical device company concentrating on early detection and treatment of reproductive-tract cancers, today announced the appointment of Floyd Taub M.D. as chief executive officer. Former CEO Dr. Augusto Ocana will serve as a consultant to CytoCore for domestic and international sales.
